Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
2(18%)
Results Posted
67%(4 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_4
1
9%
Ph not_applicable
2
18%
Ph phase_2
3
27%
Ph phase_3
3
27%

Phase Distribution

0

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Recruiting2
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (33.3%)
Phase 33 (33.3%)
Phase 41 (11.1%)
N/A2 (22.2%)

Trials by Status

recruiting218%
unknown19%
completed655%
terminated218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11